Indegene Limited (NSE:INDGN)

Market Cap	115.30B -20.1%
Revenue (ttm)	32.63B +18.4%
Net Income	4.39B +14.4%
EPS	18.21 +11.5%
Shares Out	240.01M
PE Ratio	26.38
Forward PE	23.24
Dividend	2.00 (0.41%)
Ex-Dividend Date	n/a

Volume	222,874
Average Volume	229,435
Open	480.45
Previous Close	480.40
Day's Range	477.50 - 496.00
52-Week Range	455.60 - 640.10
Beta	n/a
RSI	38.39
Earnings Date	Jan 29, 2026

About Indegene

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technolo...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1998
• Employees: 4,158
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INDGN

Financial Performance

In fiscal year 2025, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.